Mind Medicine (MindMed) Inc Sustainability Reports
A clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders. It focuses on the clinical and therapeutic applications of psychedelic and psychoplastogenic drugs for psychiatric conditions.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300QY8KN1O6RPFJ13
3 reports from 2021 to 2023
